You are here:
Home
NICE Guidance
Conditions and diseases
Diabetes and other endocrinal, nutritional and metabolic conditions
Thyroid disorders
Teprotumumab for treating thyroid eye disease (deferred appraisal of D1) [ID6756]
In development
Reference number:
GID-TA11995
Expected publication date:
03 September 2026
Project information
Project documents
Documents
Documents created during the development process.
Committee meetings
Committee meeting: 2
Back to top